Introduction Combinations of psychotherapy with antidepressants are gold-standard
psychiatric treatments. They operate through complex and interactional mechanisms, not …

Psychedelics have shown great promise in modern clinical trials for treating various
psychiatric conditions. As a transdiagnostic treatment that exerts its effects through …

Classical psychedelics, primarily psilocybin and lysergic acid diethylamide (LSD), have
been used and extensively studied in Western medicine as part of substance-assisted …

Classic psychedelics and related substances have shown promising initial research results.
However, they raise a number of relatively novel ethical and policy challenges in light of …

The purpose of this commentary is to provide an introduction to this special issue of
Neuropharmacology with a historical perspective of psychedelic drug research, their use in …

Abstract Purpose of Review Few treatments are available for patients with mood disorders or
post-traumatic stress disorder (PTSD) who have already failed multiple interventions. After …

In clinical research settings around the world, renewed investigations are taking place on
the use of psychedelic substances for treating illnesses such as addiction, depression …

In recent years, psychedelic-assisted psychotherapies have reentered the realm of rigorous
scientific inquiry, garnering much attention from both the psychiatric community and the …

The publication in April 2021 of the Imperial College London Phase II study investigating the
efficacy of psilocybin-assisted therapy vs. escitalopram for depression reported differences …

Research in the last decade has expressed considerable optimism about the clinical
potential of psychedelics for the treatment of mental disorders. This optimism is reflected in …